Stone Run Capital, LLC Laboratory Corp Of America Holdings Transaction History

Stone Run Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$104.32 - $195.28 $1.8 Million - $3.38 Million	-17,287 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $1,729 - $2,074	12 Added 0.07%	17,287 $2.99 Million
Q1 2019 May 14, 2019	SELL	$123.7 - $156.3 $1,484 - $1,875	-12 Reduced 0.07%	17,275 $2.64 Million
Q4 2018 Feb 14, 2019	SELL	$120.82 - $174.09 $495,362 - $713,769	-4,100 Reduced 19.17%	17,287 $2.19 Million
Q3 2018 Nov 14, 2018	BUY	$167.67 - $188.27 $25,150 - $28,240	150 Added 0.71%	21,387 $3.71 Million
Q2 2018 Aug 14, 2018	SELL	$160.33 - $189.41 $8,016 - $9,470	-50 Reduced 0.23%	21,237 $3.81 Million
Q1 2018 May 14, 2018	BUY	$161.53 - $178.11 $339,213 - $374,031	2,100 Added 10.94%	21,287 $3.44 Million
Q3 2017 Nov 14, 2017	BUY	$149.47 - $160.56 $2.87 Million - $3.08 Million	19,187	19,187 $2.9 Million

109

2.31M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Run Capital, LLC with notifications on news.